[New macrolides, azalides and streptogramins; current role and their future perspective].
Hoepelman
I M
IM
Rockefeller University, Laboratory of Molecular Infectious Diseases, New York, NY 10021.
Verhoef
J
J
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001372:Aza Compounds / Q000627:therapeutic use; D004347:Drug Interactions; D004917:Erythromycin / Q000031:analogs & derivatives*; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D014769:Virginiamycin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D014769:Virginiamycin; D004917:Erythromycin
Nieuwe macroliden, azaliden en streptograminen; de huidige plaats en hun toekomstperspectief.